Analysis of Long-term (Investment) Activity Ratios
Quarterly Data
Activity ratios measure how efficiently a company performs day-to-day tasks, such us the collection of receivables and management of inventory.
Long-term Activity Ratios (Summary)
Becton, Dickinson & Co., long-term (investment) activity ratios (quarterly data)
Based on: 10-Q (reporting date: 2022-03-31), 10-Q (reporting date: 2021-12-31), 10-K (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-Q (reporting date: 2020-12-31), 10-K (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-Q (reporting date: 2019-12-31), 10-K (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-Q (reporting date: 2018-12-31), 10-K (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-Q (reporting date: 2017-12-31), 10-K (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31), 10-Q (reporting date: 2016-12-31), 10-K (reporting date: 2016-09-30), 10-Q (reporting date: 2016-06-30), 10-Q (reporting date: 2016-03-31), 10-Q (reporting date: 2015-12-31).
| Long-term activity ratio | Description | The company |
|---|---|---|
| Net fixed asset turnover | An activity ratio calculated as total revenue divided by net fixed assets. | Becton, Dickinson & Co. net fixed asset turnover ratio deteriorated from Q4 2021 to Q1 2022 but then slightly improved from Q1 2022 to Q2 2022. |
| Total asset turnover | An activity ratio calculated as total revenue divided by total assets. | Becton, Dickinson & Co. total asset turnover ratio deteriorated from Q4 2021 to Q1 2022 and from Q1 2022 to Q2 2022. |
| Equity turnover | An activity ratio calculated as total revenue divided by shareholders’ equity. | Becton, Dickinson & Co. equity turnover ratio deteriorated from Q4 2021 to Q1 2022 and from Q1 2022 to Q2 2022. |
Net Fixed Asset Turnover
Becton, Dickinson & Co., net fixed asset turnover calculation (quarterly data)
| Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||||||||||||||||||||||||||||||
| Revenues | 5,011) | 4,995) | 5,136) | 4,890) | 4,907) | 5,315) | 4,784) | 3,855) | 4,253) | 4,225) | 4,585) | 4,350) | 4,195) | 4,160) | 4,403) | 4,278) | 4,222) | 3,080) | 3,167) | 3,035) | 2,969) | 2,922) | 3,232) | 3,198) | 3,067) | 2,986) | ||||||||
| Property, plant and equipment, net | 6,406) | 6,384) | 6,393) | 6,164) | 6,142) | 6,096) | 5,923) | 5,841) | 5,664) | 5,782) | 5,659) | 5,550) | 5,473) | 5,362) | 5,375) | 5,321) | 5,411) | 5,262) | 4,638) | 4,410) | 3,941) | 3,827) | 3,901) | 3,813) | 3,779) | 3,957) | ||||||||
| Long-term Activity Ratio | ||||||||||||||||||||||||||||||||||
| Net fixed asset turnover1 | 3.13 | 3.12 | 3.17 | 3.23 | 3.07 | 2.99 | 2.89 | 2.90 | 3.07 | 3.00 | 3.06 | 3.08 | 3.11 | 3.18 | 2.97 | 2.77 | 2.50 | 2.33 | 2.61 | 2.76 | 3.13 | 3.25 | 3.20 | — | — | — | ||||||||
| Benchmarks | ||||||||||||||||||||||||||||||||||
| Net Fixed Asset Turnover, Competitors2 | ||||||||||||||||||||||||||||||||||
| Abbott Laboratories | 5.17 | 5.00 | 4.81 | 4.79 | 4.56 | 4.23 | 3.83 | 3.74 | 3.77 | 4.06 | 3.97 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Cigna Group | 48.61 | 47.95 | 46.73 | 41.42 | 40.56 | 39.29 | 37.85 | 37.05 | 36.02 | 35.37 | 34.45 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| CVS Health Corp. | 24.05 | 23.26 | 22.56 | 22.24 | 21.90 | 21.42 | 21.25 | 21.48 | 21.52 | 21.49 | 21.24 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Elevance Health Inc. | 36.17 | 35.81 | 34.94 | 34.54 | 34.17 | 34.94 | 34.69 | 34.61 | 32.74 | 32.30 | 32.92 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Humana Inc. | 28.64 | 27.05 | 26.97 | 27.83 | 29.47 | 31.04 | 32.05 | 32.90 | 33.07 | 33.20 | 32.93 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Intuitive Surgical Inc. | 2.83 | 3.00 | 3.04 | 3.16 | 3.13 | 2.86 | 2.76 | 2.85 | 3.00 | 3.36 | 3.52 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Medtronic PLC | 6.13 | 6.12 | 5.77 | 5.56 | 5.64 | 5.72 | 5.99 | 6.52 | 6.50 | 6.51 | 6.54 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| UnitedHealth Group Inc. | 32.33 | 32.16 | 31.81 | 31.77 | 30.94 | 30.76 | 29.64 | 30.80 | 30.30 | 29.91 | 27.60 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
Based on: 10-Q (reporting date: 2022-03-31), 10-Q (reporting date: 2021-12-31), 10-K (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-Q (reporting date: 2020-12-31), 10-K (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-Q (reporting date: 2019-12-31), 10-K (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-Q (reporting date: 2018-12-31), 10-K (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-Q (reporting date: 2017-12-31), 10-K (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31), 10-Q (reporting date: 2016-12-31), 10-K (reporting date: 2016-09-30), 10-Q (reporting date: 2016-06-30), 10-Q (reporting date: 2016-03-31), 10-Q (reporting date: 2015-12-31).
1 Q2 2022 Calculation
Net fixed asset turnover
= (RevenuesQ2 2022
+ RevenuesQ1 2022
+ RevenuesQ4 2021
+ RevenuesQ3 2021)
÷ Property, plant and equipment, net
= (5,011 + 4,995 + 5,136 + 4,890)
÷ 6,406 = 3.13
2 Click competitor name to see calculations.
| Long-term activity ratio | Description | The company |
|---|---|---|
| Net fixed asset turnover | An activity ratio calculated as total revenue divided by net fixed assets. | Becton, Dickinson & Co. net fixed asset turnover ratio deteriorated from Q4 2021 to Q1 2022 but then slightly improved from Q1 2022 to Q2 2022. |
Total Asset Turnover
Becton, Dickinson & Co., total asset turnover calculation (quarterly data)
| Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||||||||||||||||||||||||||||||
| Revenues | 5,011) | 4,995) | 5,136) | 4,890) | 4,907) | 5,315) | 4,784) | 3,855) | 4,253) | 4,225) | 4,585) | 4,350) | 4,195) | 4,160) | 4,403) | 4,278) | 4,222) | 3,080) | 3,167) | 3,035) | 2,969) | 2,922) | 3,232) | 3,198) | 3,067) | 2,986) | ||||||||
| Total assets | 54,786) | 53,363) | 53,866) | 54,333) | 54,921) | 54,748) | 54,012) | 53,959) | 53,516) | 51,952) | 51,765) | 52,233) | 52,598) | 52,932) | 53,904) | 53,977) | 54,573) | 55,363) | 37,734) | 37,166) | 24,121) | 24,318) | 25,586) | 26,016) | 26,236) | 26,046) | ||||||||
| Long-term Activity Ratio | ||||||||||||||||||||||||||||||||||
| Total asset turnover1 | 0.37 | 0.37 | 0.38 | 0.37 | 0.34 | 0.33 | 0.32 | 0.31 | 0.33 | 0.33 | 0.33 | 0.33 | 0.32 | 0.32 | 0.30 | 0.27 | 0.25 | 0.22 | 0.32 | 0.33 | 0.51 | 0.51 | 0.49 | — | — | — | ||||||||
| Benchmarks | ||||||||||||||||||||||||||||||||||
| Total Asset Turnover, Competitors2 | ||||||||||||||||||||||||||||||||||
| Abbott Laboratories | 0.61 | 0.60 | 0.57 | 0.57 | 0.55 | 0.51 | 0.48 | 0.47 | 0.46 | 0.48 | 0.47 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Cigna Group | 1.17 | 1.15 | 1.11 | 1.09 | 1.07 | 1.06 | 1.02 | 0.97 | 0.96 | 0.99 | 0.98 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| CVS Health Corp. | 1.33 | 1.28 | 1.25 | 1.21 | 1.20 | 1.18 | 1.16 | 1.14 | 1.12 | 1.13 | 1.15 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Elevance Health Inc. | 1.47 | 1.42 | 1.41 | 1.35 | 1.33 | 1.29 | 1.39 | 1.34 | 1.28 | 1.31 | 1.33 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Humana Inc. | 1.91 | 1.86 | 1.87 | 1.78 | 2.08 | 2.08 | 2.17 | 1.90 | 1.82 | 1.94 | 2.21 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Intuitive Surgical Inc. | 0.44 | 0.43 | 0.42 | 0.42 | 0.42 | 0.39 | 0.39 | 0.41 | 0.43 | 0.47 | 0.46 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Medtronic PLC | 0.35 | 0.34 | 0.32 | 0.29 | 0.29 | 0.30 | 0.32 | 0.33 | 0.34 | 0.34 | 0.34 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| UnitedHealth Group Inc. | 1.32 | 1.33 | 1.34 | 1.30 | 1.29 | 1.27 | 1.30 | 1.31 | 1.28 | 1.29 | 1.38 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
Based on: 10-Q (reporting date: 2022-03-31), 10-Q (reporting date: 2021-12-31), 10-K (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-Q (reporting date: 2020-12-31), 10-K (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-Q (reporting date: 2019-12-31), 10-K (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-Q (reporting date: 2018-12-31), 10-K (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-Q (reporting date: 2017-12-31), 10-K (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31), 10-Q (reporting date: 2016-12-31), 10-K (reporting date: 2016-09-30), 10-Q (reporting date: 2016-06-30), 10-Q (reporting date: 2016-03-31), 10-Q (reporting date: 2015-12-31).
1 Q2 2022 Calculation
Total asset turnover
= (RevenuesQ2 2022
+ RevenuesQ1 2022
+ RevenuesQ4 2021
+ RevenuesQ3 2021)
÷ Total assets
= (5,011 + 4,995 + 5,136 + 4,890)
÷ 54,786 = 0.37
2 Click competitor name to see calculations.
| Long-term activity ratio | Description | The company |
|---|---|---|
| Total asset turnover | An activity ratio calculated as total revenue divided by total assets. | Becton, Dickinson & Co. total asset turnover ratio deteriorated from Q4 2021 to Q1 2022 and from Q1 2022 to Q2 2022. |
Equity Turnover
Becton, Dickinson & Co., equity turnover calculation (quarterly data)
| Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||||||||||||||||||||||||||||||
| Revenues | 5,011) | 4,995) | 5,136) | 4,890) | 4,907) | 5,315) | 4,784) | 3,855) | 4,253) | 4,225) | 4,585) | 4,350) | 4,195) | 4,160) | 4,403) | 4,278) | 4,222) | 3,080) | 3,167) | 3,035) | 2,969) | 2,922) | 3,232) | 3,198) | 3,067) | 2,986) | ||||||||
| Shareholders’ equity | 24,525) | 24,160) | 23,677) | 24,135) | 24,826) | 24,663) | 23,765) | 24,022) | 20,951) | 21,202) | 21,081) | 21,497) | 21,310) | 21,403) | 20,994) | 21,358) | 21,152) | 21,247) | 12,948) | 12,587) | 7,963) | 7,583) | 7,633) | 8,033) | 7,666) | 7,223) | ||||||||
| Long-term Activity Ratio | ||||||||||||||||||||||||||||||||||
| Equity turnover1 | 0.82 | 0.82 | 0.86 | 0.82 | 0.76 | 0.74 | 0.72 | 0.70 | 0.83 | 0.82 | 0.82 | 0.80 | 0.80 | 0.80 | 0.76 | 0.69 | 0.64 | 0.58 | 0.93 | 0.97 | 1.55 | 1.64 | 1.64 | — | — | — | ||||||||
| Benchmarks | ||||||||||||||||||||||||||||||||||
| Equity Turnover, Competitors2 | ||||||||||||||||||||||||||||||||||
| Abbott Laboratories | 1.25 | 1.26 | 1.20 | 1.23 | 1.19 | 1.11 | 1.06 | 1.03 | 1.03 | 1.06 | 1.03 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Cigna Group | 3.88 | 3.81 | 3.66 | 3.56 | 3.40 | 3.36 | 3.16 | 3.24 | 3.24 | 3.39 | 3.36 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| CVS Health Corp. | 4.08 | 4.05 | 3.87 | 3.82 | 3.79 | 3.81 | 3.86 | 3.86 | 3.87 | 4.01 | 4.00 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Elevance Health Inc. | 4.13 | 3.97 | 3.80 | 3.71 | 3.65 | 3.65 | 3.64 | 3.43 | 3.26 | 3.41 | 3.25 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Humana Inc. | 5.77 | 5.63 | 5.15 | 4.96 | 5.34 | 5.48 | 5.54 | 4.65 | 4.86 | 5.44 | 5.35 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Intuitive Surgical Inc. | 0.50 | 0.49 | 0.48 | 0.48 | 0.48 | 0.45 | 0.45 | 0.47 | 0.50 | 0.54 | 0.54 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Medtronic PLC | 0.61 | 0.61 | 0.59 | 0.55 | 0.56 | 0.56 | 0.57 | 0.60 | 0.61 | 0.61 | 0.61 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| UnitedHealth Group Inc. | 4.18 | 4.06 | 3.98 | 3.95 | 3.92 | 3.94 | 3.90 | 3.85 | 3.87 | 4.29 | 4.17 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
Based on: 10-Q (reporting date: 2022-03-31), 10-Q (reporting date: 2021-12-31), 10-K (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-Q (reporting date: 2020-12-31), 10-K (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-Q (reporting date: 2019-12-31), 10-K (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-Q (reporting date: 2018-12-31), 10-K (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-Q (reporting date: 2017-12-31), 10-K (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31), 10-Q (reporting date: 2016-12-31), 10-K (reporting date: 2016-09-30), 10-Q (reporting date: 2016-06-30), 10-Q (reporting date: 2016-03-31), 10-Q (reporting date: 2015-12-31).
1 Q2 2022 Calculation
Equity turnover
= (RevenuesQ2 2022
+ RevenuesQ1 2022
+ RevenuesQ4 2021
+ RevenuesQ3 2021)
÷ Shareholders’ equity
= (5,011 + 4,995 + 5,136 + 4,890)
÷ 24,525 = 0.82
2 Click competitor name to see calculations.
| Long-term activity ratio | Description | The company |
|---|---|---|
| Equity turnover | An activity ratio calculated as total revenue divided by shareholders’ equity. | Becton, Dickinson & Co. equity turnover ratio deteriorated from Q4 2021 to Q1 2022 and from Q1 2022 to Q2 2022. |